Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;71(4):514-21.
doi: 10.1111/j.1365-2125.2010.03894.x.

Inverse relationship between leukaemic cell burden and plasma concentrations of daunorubicin in patients with acute myeloid leukaemia

Alex Bogason  1 , Angelica L Quartino, Pierre Lafolie, Michèle Masquelier, Mats O Karlsson, Christer Paul, Astrid Gruber, Sigurd Vitols
Affiliations

Inverse relationship between leukaemic cell burden and plasma concentrations of daunorubicin in patients with acute myeloid leukaemia

Alex Bogason et al. Br J Clin Pharmacol. 2011 Apr.

Abstract

Aims: It has been shown that the cellular uptake and cytotoxicity of anthracyclines decrease with increasing cell density in vitro, an event termed 'the inocculum effect'. It is not known whether such an effect occurs in vivo. In this study the relationships between white blood cell (WBC) count, plasma and cellular concentrations of daunorubicin (DNR) in patients with acute myeloid leukaemia were investigated.

Methods: Plasma and mononuclear blood cells were isolated from peripheral blood from 40 patients with acute myeloid leukaemia at end of infusion (time 1 h), 5 and 24 h following the first DNR infusion. DNR concentrations were determined by high-pressure liquid chromatography and related to the WBC count at diagnosis. A population pharmacokinetic model was used to estimate the correlations between baseline WBC count, volume of distribution and clearance of DNR.

Results: A clear but weak inverse relationship between the baseline WBC count and plasma concentrations of DNR (r(2)=0.11, P<0.05) at time 1 was found. Furthermore, a clear relationship between baseline WBC count and DNR central volume of distribution using population pharmacokinetic modelling (dOFV 4.77, P<0.05) was also noted. Analysis of plasma DNR and the metabolite daunorubicinol (DOL) concentrations in patients with a high WBC count support that the low DNR/DOL concentrations are due a distribution effect.

Conclusion: This study shows that the leukaemic cell burden influences the plasma concentrations of anthracyclines. Further studies are needed to explore if patients with high a WBC count may require higher doses of anthracyclines.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Plasma daunorubicin (DNR) concentrations in relation to white blood cell (WBC) count in acute myeloid leukaemia patients (n = 40) directly after a 1-h DNR infusion. The dotted lines represent the 95% confidence limits
Figure 2
Figure 2
Plasma concentration of daunorubicin (DNR) in relation to plasma concentration of daunorubicinol (DOL) in acute myeloid leukaemia patients (n = 40) directly after a 1-h DNR infusion. The dotted lines represent the 95% confidence limits
Figure 3
Figure 3
Intracellular concentration of daunorubicin (DNR) in relation to white blood cell (WBC) count in acute myeloid leukaemia patients (n = 24) directly after a 1-h DNR infusion
Figure 4
Figure 4
Visual predictive checks (80% prediction interval) based on the population pharmacokinetic model by Callies et al. superimposed on the observed DNR and DOL plasma concentrations. Observed data (dots) and the 95% confidence intervals around the simulated median (dark grey), 10th and 90th percentiles (light grey) are shown. Solid and dotted lines are the corresponding median and percentiles, respectively, of the observed data
Figure 5
Figure 5
Visual predictive checks (80% prediction interval) for (A) the basic population pharmacokinetic (PK) model of daunorubicin (DNR) in plasma and (B) for the model including white blood cell (WBC) counts. Observed data (dots) and the 95% confidence intervals around the simulated median (dark grey), 10th and 90th percentiles (light grey) are shown. Solid and dotted lines are the corresponding median and percentiles, respectively, of the observed data
See this image and copyright information in PMC

References

    1. Novitzky N, Thomas V, Abrahams L, du Toit C, McDonald A. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia. Am J Hematol. 2004;76:319–29. - PubMed
    1. Palle J, Frost BM, Peterson C, Gustafsson G, Hellebostad M, Kanerva J, Schmiegelow K, Lonnerholm G. Doxorubicin pharmacokinetics are correlated to the effect of induction therapy in children with acute myeloid leukemia. Anticancer Drugs. 2006;17:385–92. - PubMed
    1. Masquelier M, Vitols S. Drastic effect of cell density on the cytotoxicity of daunorubicin and cytosine arabinoside. Biochem Pharmacol. 2004;67:1639–46. - PubMed
    1. Kobayashi H, Takemura Y, Ohnuma T. Relationship between tumor cell density and drug concentration and the cytotoxic effects of doxorubicin or vincristine: mechanism of inoculum effects. Cancer Chemother Pharmacol. 1992;31:6–10. - PubMed
    1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976;33:451–8. - PubMed

Publication types